Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
JCI Insight ; 5(20)2020 10 15.
Article in English | MEDLINE | ID: mdl-33055427

ABSTRACT

Phenylalanine hydroxylase-deficient (PAH-deficient) phenylketonuria (PKU) results in systemic hyperphenylalaninemia, leading to neurotoxicity with severe developmental disabilities. Dietary phenylalanine (Phe) restriction prevents the most deleterious effects of hyperphenylalaninemia, but adherence to diet is poor in adult and adolescent patients, resulting in characteristic neurobehavioral phenotypes. Thus, an urgent need exists for new treatments. Additionally, rodent models of PKU do not adequately reflect neurocognitive phenotypes, and thus there is a need for improved animal models. To this end, we have developed PAH-null pigs. After selection of optimal CRISPR/Cas9 genome-editing reagents by using an in vitro cell model, zygote injection of 2 sgRNAs and Cas9 mRNA demonstrated deletions in preimplantation embryos, with embryo transfer to a surrogate leading to 2 founder animals. One pig was heterozygous for a PAH exon 6 deletion allele, while the other was compound heterozygous for deletions of exon 6 and of exons 6-7. The affected pig exhibited hyperphenylalaninemia (2000-5000 µM) that was treatable by dietary Phe restriction, consistent with classical PKU, along with juvenile growth retardation, hypopigmentation, ventriculomegaly, and decreased brain gray matter volume. In conclusion, we have established a large-animal preclinical model of PKU to investigate pathophysiology and to assess new therapeutic interventions.


Subject(s)
Liver/metabolism , Phenylalanine Hydroxylase/genetics , Phenylalanine/genetics , Phenylketonurias/genetics , Adolescent , Adult , Animals , CRISPR-Cas Systems/genetics , Diet , Disease Models, Animal , Gene Editing , Humans , Liver/drug effects , Phenotype , Phenylalanine/metabolism , Phenylalanine/pharmacology , Phenylketonurias/diet therapy , Phenylketonurias/metabolism , Phenylketonurias/pathology , Swine
3.
Am J Transplant ; 19(8): 2174-2185, 2019 08.
Article in English | MEDLINE | ID: mdl-30821922

ABSTRACT

The shortage of available organs remains the greatest barrier to expanding access to transplant. Despite advances in genetic editing and immunosuppression, survival in experimental models of kidney xenotransplant has generally been limited to <100 days. We found that pretransplant selection of recipients with low titers of anti-pig antibodies significantly improved survival in a pig-to-rhesus macaque kidney transplant model (6 days vs median survival time 235 days). Immunosuppression included transient pan-T cell depletion and an anti-CD154-based maintenance regimen. Selective depletion of CD4+ T cells but not CD8+ T cells resulted in long-term survival (median survival time >400 days vs 6 days). These studies suggested that CD4+ T cells may have a more prominent role in xenograft rejection compared with CD8+ T cells. Although animals that received selective depletion of CD8+ T cells showed signs of early cellular rejection (marked CD4+ infiltrates), animals receiving selective CD4+ depletion exhibited normal biopsy results until late, when signs of chronic antibody rejection were present. In vitro study results suggested that rhesus CD4+ T cells required the presence of SLA class II to mount an effective proliferative response. The combination of low pretransplant anti-pig antibody and CD4 depletion resulted in consistent, long-term xenograft survival.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Graft Rejection/etiology , Graft Survival/immunology , Immune Tolerance/immunology , Kidney Transplantation/adverse effects , Lymphocyte Depletion/adverse effects , Animals , Graft Rejection/pathology , Heterografts , Macaca mulatta , Swine
4.
Invest Ophthalmol Vis Sci ; 59(6): 2325-2338, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29847637

ABSTRACT

Purpose: Recent clinical data suggest an increasing prevalence of obesity and type 2 diabetes in adolescents, placing them at high risk of developing diabetic retinopathy during adult working years. The present study was designed to characterize the early retinal and microvascular alterations in young Ossabaw pigs fed a Western diet, described as a model of metabolic syndrome genetically predisposed to type 2 diabetes. Methods: Four-month-old Ossabaw miniature pigs were divided into two groups, lean and diet-induced obesity. Obese pigs were fed a Western diet with high-fat/high-fructose corn syrup/high-choleric content for 10 weeks. Blood and retina were collected for biochemical profiling, trypsin digest, flatmounts, Fluoro-Jade C staining, electron microscopy, quantitative PCR, immunohistochemistry, and Western blots. Results: Young Ossabaw pigs had elevated fasting blood glucose after feeding on a Western diet for 10 weeks. Their retina showed disrupted cellular architecture across neural layers, with numerous large vacuoles seen in cell bodies of the inner nuclear layer. Microvessels in the obese animals exhibited thickened basement membrane, along with pericyte ghosts and acellular capillaries. The pericyte to endothelial ratio decreased significantly. Retina flatmounts from obese pigs displayed reduced capillary density, numerous terminal capillary loops, and string vessels, which stained collagen IV but not isolectin IB4. Quantitative PCR and Western blots showed significantly high levels of basement membrane proteins collagen IV and fibronectin in obese pigs. Conclusions: This is the first study to describe the ultrastructural neuronal and vascular changes in the retina of young Ossabaw pigs fed a Western diet, simulating early signs of diabetic retinopathy pathogenesis.


Subject(s)
Basement Membrane/ultrastructure , Diabetes Mellitus, Experimental , Diabetic Retinopathy/diagnosis , Diet, Western/adverse effects , Retina/ultrastructure , Animals , Diabetic Retinopathy/etiology , Female , Follow-Up Studies , Male , Microscopy, Electron , Swine , Swine, Miniature , Time Factors
5.
Am J Physiol Regul Integr Comp Physiol ; 314(2): R252-R264, 2018 02 01.
Article in English | MEDLINE | ID: mdl-29141949

ABSTRACT

Impaired microvascular insulin signaling may develop before overt indices of microvascular endothelial dysfunction and represent an early pathological feature of adolescent obesity. Using a translational porcine model of juvenile obesity, we tested the hypotheses that in the early stages of obesity development, impaired insulin signaling manifests in skeletal muscle (triceps), brain (prefrontal cortex), and corresponding vasculatures, and that depressed insulin-induced vasodilation is reversible with acute inhibition of protein kinase Cß (PKCß). Juvenile Ossabaw miniature swine (3.5 mo of age) were divided into two groups: lean control ( n = 6) and obese ( n = 6). Obesity was induced by feeding the animals a high-fat/high-fructose corn syrup/high-cholesterol diet for 10 wk. Juvenile obesity was characterized by excess body mass, hyperglycemia, physical inactivity (accelerometer), and marked lipid accumulation in the skeletal muscle, with no evidence of overt atherosclerotic lesions in athero-prone regions, such as the abdominal aorta. Endothelium-dependent (bradykinin) and -independent (sodium nitroprusside) vasomotor responses in the brachial and carotid arteries (wire myography), as well as in the skeletal muscle resistance and 2A pial arterioles (pressure myography) were unaltered, but insulin-induced microvascular vasodilation was impaired in the obese group. Blunted insulin-stimulated vasodilation, which was reversed with acute PKCß inhibition (LY333-531), occurred alongside decreased tissue perfusion, as well as reduced insulin-stimulated Akt signaling in the prefrontal cortex, but not the triceps. In the early stages of juvenile obesity development, the microvasculature and prefrontal cortex exhibit impaired insulin signaling. Such adaptations may underscore vascular and neurological derangements associated with juvenile obesity.


Subject(s)
Insulin Resistance , Insulin/blood , Microvessels/metabolism , Muscle, Skeletal/blood supply , Pediatric Obesity/metabolism , Prefrontal Cortex/blood supply , Vasodilation , Age Factors , Animals , Disease Models, Animal , Disease Progression , Female , Male , Microvessels/drug effects , Microvessels/physiopathology , Pediatric Obesity/physiopathology , Phosphorylation , Protein Kinase C beta/antagonists & inhibitors , Protein Kinase C beta/metabolism , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , Swine , Swine, Miniature , Time Factors , Vasodilation/drug effects
9.
Lab Anim (NY) ; 46(4): 167-172, 2017 Mar 22.
Article in English | MEDLINE | ID: mdl-28328880

ABSTRACT

The pig is becoming increasingly important as a biomedical model. Given the similarities between pigs and humans, a greater understanding of the underlying biology of human health and diseases may come from the pig rather than from classical rodent models. With an increasing need for swine models, it is essential that the genomic tools, models and services be readily available to the scientific community. Many of these are available through the National Swine Resource and Research Center (NSRRC), a facility funded by the US National Institutes of Health at the University of Missouri. The goal of the NSRRC is to provide high-quality biomedical swine models to the scientific community.


Subject(s)
Models, Animal , Swine/genetics , Animals , Animals, Genetically Modified , Cystic Fibrosis/genetics , Disease Models, Animal , Neoplasms/genetics , Retinitis Pigmentosa/genetics
10.
Sci Rep ; 5: 14176, 2015 Sep 21.
Article in English | MEDLINE | ID: mdl-26387706

ABSTRACT

Both the low animal cell density of bioreactors and their ability to post-translationally process recombinant factor IX (rFIX) limit hemophilia B therapy to <20% of the world's population. We used transgenic pigs to make rFIX in milk at about 3,000-fold higher output than provided by industrial bioreactors. However, this resulted in incomplete γ-carboxylation and propeptide cleavage where both processes are transmembrane mediated. We then bioengineered the co-expression of truncated, soluble human furin (rFurin) with pro-rFIX at a favorable enzyme to substrate ratio. This resulted in the complete conversion of pro-rFIX to rFIX while yielding a normal lactation. Importantly, these high levels of propeptide processing by soluble rFurin did not preempt γ-carboxylation in the ER and therefore was compartmentalized to the Trans-Golgi Network (TGN) and also to milk. The Golgi specific engineering demonstrated here segues the ER targeted enhancement of γ-carboxylation needed to biomanufacture coagulation proteins like rFIX using transgenic livestock.


Subject(s)
Factor IX/genetics , Furin/genetics , Hemophilia B/therapy , Mammary Glands, Animal/metabolism , Milk/metabolism , Protein Engineering/methods , Animals , Animals, Genetically Modified , Bioreactors , Factor IX/metabolism , Factor IX/therapeutic use , Female , Furin/metabolism , Humans , Lactation/metabolism , Male , Protein Processing, Post-Translational , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/therapeutic use , Swine
11.
Theriogenology ; 84(6): 1024-32, 2015 Oct 01.
Article in English | MEDLINE | ID: mdl-26143360

ABSTRACT

Artificial oocyte activation is a critical step during SCNT. Most current activation protocols focus on inducing an increase in the intracellular free Ca(2+) concentration of the oocyte. Here, we have used a zinc chelator, TPEN, to enhance the efficiency of oocyte activation during SCNT. TPEN treatment of matured pig oocytes resulted in the reduction of available Zn(2+) in pig oocytes; however, the cytosolic Ca(2+) concentration in the oocytes was not affected by the TPEN treatment. When various concentrations (100-250 µM) and incubation durations (45 minutes-2.5 hours) of TPEN were used to activate oocytes, the efficiency of oocyte activation was not different from conventional activation methods. When oocytes that were activated by conventional activation methods were incubated with a lower concentration of TPEN (5-10 µM), a significant increase in embryos developing to the blastocyst stage was observed. In addition, when oocytes receiving a small Ca(2+) stimulus were further activated by higher concentration of TPEN (100-200 µM), a significant increase in the frequency of blastocyst formation was observed, compared to a conventional activation method. This result indicated that TPEN can be a main reagent in oocyte activation. No increase in the cytosolic Ca(2+) level was detected when oocytes were exposed to various concentrations of TPEN, indicating the ability of TPEN to induce oocyte activation is independent of an intracellular Ca(2+) increase. We were able to produce clones through SCNT by using the TPEN-assisted activation procedure, and the piglets produced through the process did not show any signs of abnormality. In this study, we have developed an efficient way to use TPEN to increase the developmental potential of cloned embryos.


Subject(s)
Ethylenediamines/pharmacology , Nuclear Transfer Techniques/veterinary , Oocytes/drug effects , Swine/physiology , Zinc/chemistry , Animals , Calcium/metabolism , Embryonic Development , In Vitro Oocyte Maturation Techniques/methods , In Vitro Oocyte Maturation Techniques/veterinary , Oocytes/metabolism , Oocytes/physiology
12.
PLoS One ; 10(7): e0128864, 2015.
Article in English | MEDLINE | ID: mdl-26132737

ABSTRACT

The large size of the pig and its similarity in anatomy, physiology, metabolism, and genetics to humans make it an ideal platform to develop a genetically defined, large animal model of cancer. To this end, we created a transgenic "oncopig" line encoding Cre recombinase inducible porcine transgenes encoding KRASG12D and TP53R167H, which represent a commonly mutated oncogene and tumor suppressor in human cancers, respectively. Treatment of cells derived from these oncopigs with the adenovirus encoding Cre (AdCre) led to KRASG12D and TP53R167H expression, which rendered the cells transformed in culture and tumorigenic when engrafted into immunocompromised mice. Finally, injection of AdCre directly into these oncopigs led to the rapid and reproducible tumor development of mesenchymal origin. Transgenic animals receiving AdGFP (green fluorescent protein) did not have any tumor mass formation or altered histopathology. This oncopig line could thus serve as a genetically malleable model for potentially a wide spectrum of cancers, while controlling for temporal or spatial genesis, which should prove invaluable to studies previously hampered by the lack of a large animal model of cancer.


Subject(s)
Genetic Predisposition to Disease , Neoplasms/genetics , Neoplasms/pathology , Animals , Animals, Genetically Modified , Cell Transformation, Neoplastic/genetics , Disease Models, Animal , Female , Fibroblasts/metabolism , Fibroblasts/pathology , Gene Expression , Gene Order , Gene Targeting , Genes, Reporter , Genes, p53 , Genes, ras , Heterografts , Male , Mice , Swine , Transcriptional Activation , Transgenes
13.
Mamm Genome ; 26(5-6): 264-70, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25930071

ABSTRACT

Studies in mice genetically lacking natural killer T (NKT) cells show that these lymphocytes make important contributions to both innate and adaptive immune responses. However, the usefulness of murine models to study human NKT cells is limited by the many differences between mice and humans, including that their NKT cell frequencies, subsets, and distribution are dissimilar. A more suitable model may be swine that share many metabolic, physiological, and growth characteristics with humans and are also similar for NKT cells. Thus, we analyzed genetically modified pigs made deficient for CD1d that is required for the development of Type I invariant NKT (iNKT) cells that express a semi-invariant T-cell receptor (TCR) and Type II NKT cells that use variable TCRs. Peripheral blood analyzed by flow cytometry and interferon-γ enzyme-linked immuno spot assays demonstrated that CD1d-knockout pigs completely lack iNKT cells, while other leukocyte populations remain intact. CD1d and NKT cells have been shown to be involved in shaping the composition of the commensal microbiota in mice. Therefore, we also compared the fecal microbiota profile between pigs expressing and lacking NKT cells. However, no differences were found between pigs lacking or expressing CD1d. Our results are the first to show that knocking-out CD1d prevents the development of NKT cells in a non-rodent species. CD1d-deficient pigs should offer a useful model to more accurately determine the contribution of NKT cells for human immune responses. They also have potential for understanding how NKT cells impact the health of commercial swine.


Subject(s)
Antigens, CD1d/genetics , Antigens, CD1d/immunology , Natural Killer T-Cells/immunology , Animals , Animals, Genetically Modified , Feces/microbiology , Gene Deletion , Natural Killer T-Cells/metabolism , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics , Sequence Analysis, RNA , Swine/genetics
14.
Biol Reprod ; 92(3): 72, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25609834

ABSTRACT

KDM5B (JARID1B/PLU1) is a H3K4me2/3 histone demethylase that is implicated in cancer development and proliferation and is also indispensable for embryonic stem cell self-renewal, cell fate, and murine embryonic development. However, little is known about the role of KDM5B during preimplantation embryo development. Here we show that KDM5B is critical to porcine preimplantation development. KDM5B was found to be expressed in a stage-specific manner, consistent with demethylation of H3K4me3, with the highest expression being observed from the 4-cell to the blastocyst stages. Knockdown of KDM5B by morpholino antisense oligonucleotides injection impaired porcine embryo development to the blastocyst stage. The impairment of embryo development might be caused by increased expression of H3K4me3 at the 4-cell and blastocyst stages, which disturbs the balance of bivalent H3K4me3-H3K27me3 modifications at the blastocyst stage. Decreased abundance of H3K27me3 at blastocyst stage activates multiple members of homeobox genes (HOX), which need to be silenced for faithful embryo development. Additionally, the histone demethylase KDM6A was found to be upregulated by knockdown of KDM5B, which indicated it was responsible for the decreased abundance of H3K27me3 at the blastocyst stage. The transcriptional levels of Ten-Eleven Translocation gene family members (TET1, TET2, and TET3) are found to be increased by knockdown of KDM5B, which indicates cross talk between histone modifications and DNA methylation. The studies above indicate that KDM5B is required for porcine embryo development through regulating the balance of bivalent H3K4me3-H3K27me3 modifications.


Subject(s)
Embryonic Development/physiology , Gene Knockdown Techniques , Histone Demethylases/physiology , Jumonji Domain-Containing Histone Demethylases/physiology , Swine/embryology , Swine/physiology , Amino Acid Sequence , Animals , DNA-Binding Proteins/genetics , DNA-Binding Proteins/physiology , Embryo Culture Techniques , Embryonic Development/genetics , Female , Gene Deletion , Genes, Homeobox/genetics , Genes, Homeobox/physiology , Histone Demethylases/genetics , Jumonji Domain-Containing Histone Demethylases/genetics , Methylation , Molecular Sequence Data , Swine/genetics
15.
Cell Reprogram ; 17(1): 28-40, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25548976

ABSTRACT

Faulty epigenetic reprogramming of somatic nuclei is thought to be the main reason for low cloning efficiency by somatic cell nuclear transfer (SCNT). Histone deacetylase inhibitors (HDACi), such as Scriptaid, improve developmental competence of SCNT embryos in several species. Another HDACi, Oxamflatin, is about 100 times more potent than Scriptaid in the ability to inhibit nuclear-specific HDACs. The present study determined the effects of Oxamflatin treatment on embryo development, DNA methylation, and gene expression. Oxamflatin treatment enhanced blastocyst formation of SCNT embryos in vitro. Embryo transfer produced more pigs born and fewer mummies from the Oxamflatin-treated group compared to the Scriptaid-treated positive control. Oxamflatin also decreased DNA methylation of POU5F1 regulatory elements and centromeric repeat elements in day-7 blastocysts. When compared to in vitro-fertilized (IVF) embryos, the methylation status of POU5F1, NANOG, and centromeric repeat was similar in the cloned embryos, indicating these genes were successfully reprogrammed. However, compared to the lack of methylation of XIST in day-7 IVF embryos, a higher methylation level in day-7 cloned embryos was observed, implying that X chromosomes were activated in day-7 IVF blastocysts, but were not fully activated in cloned embryos, i.e., reprogramming of XIST was delayed. A time-course analysis of XIST DNA methylation on day-13, -15, -17, and -19 in vivo embryos revealed that XIST methylation initiated at about day 13 and was not completed by day 19. The methylation of the XIST gene in day-19 control cloned embryos was delayed again when compared to in vivo embryos. However, methylation of XIST in Oxamflatin-treated embryos was comparable with in vivo embryos, which further demonstrated that Oxamflatin could accelerate the delayed reprogramming of XIST gene and thus might improve cloning efficiency.


Subject(s)
Blastocyst/cytology , Cellular Reprogramming/drug effects , Cloning, Organism/methods , Embryonic Development/drug effects , Hydroxamic Acids/pharmacology , Animals , DNA Methylation , Embryo Culture Techniques , Embryo Transfer/veterinary , Female , Histone Deacetylase Inhibitors/pharmacology , Homeodomain Proteins/metabolism , Hydroxylamines/pharmacology , Male , Nuclear Transfer Techniques/veterinary , Octamer Transcription Factor-3/metabolism , Pregnancy , Quinolines/pharmacology , RNA, Long Noncoding/metabolism , Swine
16.
Cell Reprogram ; 17(4): 243-58, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26731590

ABSTRACT

Genetically modified pigs are commonly created via somatic cell nuclear transfer (SCNT). Treatment of reconstructed embryos with histone deacetylase inhibitors (HDACi) immediately after activation improves cloning efficiency. The objective of this experiment was to evaluate the transcriptome of SCNT embryos treated with suberoylanilide hydroxamic acid (SAHA), 4-iodo-SAHA (ISAHA), or Scriptaid as compared to untreated SCNT, in vitro-fertilized (IVF), and in vivo (IVV) blastocyst-stage embryos. SAHA (10 µM) had the highest level of blastocyst development at 43.9%, and all treatments except 10 µM ISAHA had the same percentage of blastocyst development as Scriptaid (p<0.05). Two treatments, 1.0 µM ISAHA and 1.0 µM SAHA, had higher mean cell number than No HDACi treatment (p<0.021). Embryo transfers performed with 10 µM SAHA- and 1 µM ISAHA-treated embryos resulted in the birth of healthy piglets. GenBank accession numbers from up- and downregulated transcripts were loaded into the Database for Annotation, Visualization and Integrated Discovery to identify enriched biological themes. HDACi treatment yielded the highest enrichment for transcripts within the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway, lysosome. The mean intensity of LysoTracker was lower in IVV embryos compared to IVF and SCNT embryos (p<0.0001). SAHA and ISAHA can successfully be used to create healthy piglets from SCNT.


Subject(s)
Blastocyst/drug effects , Fertilization in Vitro , Histone Deacetylase Inhibitors/pharmacology , Nuclear Transfer Techniques , Sus scrofa/embryology , Transcriptome , Animals , Blastocyst/metabolism , Female , Hydroxamic Acids/analysis , Hydroxamic Acids/pharmacology , Hydroxylamines/pharmacology , Lysosomes/drug effects , Lysosomes/enzymology , Quinolines/pharmacology , Vorinostat
17.
Biol Reprod ; 91(3): 78, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25100712

ABSTRACT

Targeted modification of the pig genome can be challenging. Recent applications of the CRISPR/Cas9 system hold promise for improving the efficacy of genome editing. When a designed CRISPR/Cas9 system targeting CD163 or CD1D was introduced into somatic cells, it was highly efficient in inducing mutations. When these mutated cells were used with somatic cell nuclear transfer, offspring with these modifications were created. When the CRISPR/Cas9 system was delivered into in vitro produced presumptive porcine zygotes, the system was effective in creating mutations in eGFP, CD163, and CD1D (100% targeting efficiency in blastocyst stage embryos); however, it also presented some embryo toxicity. We could also induce deletions in CD163 or CD1D by introducing two types of CRISPRs with Cas9. The system could also disrupt two genes, CD163 and eGFP, simultaneously when two CRISPRs targeting two genes with Cas9 were delivered into zygotes. Direct injection of CRISPR/Cas9 targeting CD163 or CD1D into zygotes resulted in piglets that have mutations on both alleles with only one CD1D pig having a mosaic genotype. We show here that the CRISPR/Cas9 system can be used by two methods. The system can be used to modify somatic cells followed by somatic cell nuclear transfer. System components can also be used in in vitro produced zygotes to generate pigs with specific genetic modifications.


Subject(s)
Animals, Genetically Modified/physiology , Blastocyst/physiology , CRISPR-Cas Systems , Embryo, Mammalian/physiology , Genetic Engineering/veterinary , Oocytes/physiology , Sus scrofa/physiology , Animals , Animals, Genetically Modified/genetics , Antigens, CD/genetics , Antigens, CD/metabolism , Antigens, CD1d/chemistry , Antigens, CD1d/genetics , Antigens, CD1d/metabolism , Antigens, Differentiation, Myelomonocytic/genetics , Antigens, Differentiation, Myelomonocytic/metabolism , Cell Line , Embryo Culture Techniques/veterinary , Embryo Transfer/veterinary , Female , Fertilization in Vitro/veterinary , Gene Deletion , Genetic Engineering/adverse effects , Genetic Engineering/methods , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , In Vitro Oocyte Maturation Techniques/veterinary , Male , Mutation , Nuclear Transfer Techniques/veterinary , Receptors, Cell Surface/antagonists & inhibitors , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Sus scrofa/genetics , Transgenes
18.
Proc Natl Acad Sci U S A ; 111(20): 7260-5, 2014 May 20.
Article in English | MEDLINE | ID: mdl-24799706

ABSTRACT

Pigs with severe combined immunodeficiency (SCID) may provide useful models for regenerative medicine, xenotransplantation, and tumor development and will aid in developing therapies for human SCID patients. Using a reporter-guided transcription activator-like effector nuclease (TALEN) system, we generated targeted modifications of recombination activating gene (RAG) 2 in somatic cells at high efficiency, including some that affected both alleles. Somatic-cell nuclear transfer performed with the mutated cells produced pigs with RAG2 mutations without integrated exogenous DNA. Biallelically modified pigs either lacked a thymus or had one that was underdeveloped. Their splenic white pulp lacked B and T cells. Under a conventional housing environment, the biallelic RAG2 mutants manifested a "failure to thrive" phenotype, with signs of inflammation and apoptosis in the spleen compared with age-matched wild-type animals by the time they were 4 wk of age. Pigs raised in a clean environment were healthier and, following injection of human induced pluripotent stem cells (iPSCs), quickly developed mature teratomas representing all three germ layers. The pigs also tolerated grafts of allogeneic porcine trophoblast stem cells. These SCID pigs should have a variety of uses in transplantation biology.


Subject(s)
DNA-Binding Proteins/genetics , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/transplantation , Nuclear Proteins/genetics , Severe Combined Immunodeficiency/metabolism , Transplantation, Heterologous , Alleles , Animals , Base Sequence , Fibroblasts/metabolism , Genotype , Humans , Molecular Sequence Data , Mutation , Phenotype , Regeneration , Severe Combined Immunodeficiency/genetics , Severe Combined Immunodeficiency/therapy , Swine , Swine, Miniature , Thymus Gland/metabolism , Umbilical Cord/cytology
19.
Plant Physiol ; 164(2): 694-709, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24357601

ABSTRACT

Timing of flowering is key to the reproductive success of many plants. In temperate climates, flowering is often coordinated with seasonal environmental cues such as temperature and photoperiod. Vernalization is an example of temperature influencing the timing of flowering and is defined as the process by which a prolonged exposure to the cold of winter results in competence to flower during the following spring. In cereals, three genes (VERNALIZATION1 [VRN1], VRN2, and FLOWERING LOCUS T [FT]) have been identified that influence the vernalization requirement and are thought to form a regulatory loop to control the timing of flowering. Here, we characterize natural variation in the vernalization and photoperiod responses in Brachypodium distachyon, a small temperate grass related to wheat (Triticum aestivum) and barley (Hordeum vulgare). Brachypodium spp. accessions display a wide range of flowering responses to different photoperiods and lengths of vernalization. In addition, we characterize the expression patterns of the closest homologs of VRN1, VRN2 (VRN2-like [BdVRN2L]), and FT before, during, and after cold exposure as well as in different photoperiods. FT messenger RNA levels generally correlate with flowering time among accessions grown in different photoperiods, and FT is more highly expressed in vernalized plants after cold. VRN1 is induced by cold in leaves and remains high following vernalization. Plants overexpressing VRN1 or FT flower rapidly in the absence of vernalization, and plants overexpressing VRN1 exhibit lower BdVRN2L levels. Interestingly, BdVRN2L is induced during cold, which is a difference in the behavior of BdVRN2L compared with wheat VRN2 during cold.


Subject(s)
Brachypodium/physiology , Cold Temperature , Flowers/physiology , Photoperiod , Brachypodium/genetics , Ecotype , Flowers/genetics , Gene Expression Regulation, Plant , Genes, Plant/genetics , Plant Proteins/genetics , Plant Proteins/metabolism , Sequence Homology, Nucleic Acid , Time Factors , Up-Regulation/genetics
20.
PLoS One ; 8(10): e76594, 2013.
Article in English | MEDLINE | ID: mdl-24098537

ABSTRACT

Cyanobacteria are valuable organisms for studying the physiology of photosynthesis and carbon fixation, as well as metabolic engineering for the production of fuels and chemicals. This work describes a novel counter selection method for the cyanobacterium Synechococcus sp. PCC 7002 based on organic acid toxicity. The organic acids acrylate, 3-hydroxypropionate, and propionate were shown to be inhibitory towards Synechococcus sp. PCC 7002 and other cyanobacteria at low concentrations. Inhibition was overcome by a loss of function mutation in the gene acsA, which is annotated as an acetyl-CoA ligase. Loss of AcsA function was used as a basis for an acrylate counter selection method. DNA fragments of interest were inserted into the acsA locus and strains harboring the insertion were isolated on selective medium containing acrylate. This methodology was also used to introduce DNA fragments into a pseudogene, glpK. Application of this method will allow for more advanced genetics and engineering studies in Synechococcus sp. PCC 7002 including the construction of markerless gene deletions and insertions. The acrylate counter-selection could be applied to other cyanobacterial species where AcsA activity confers acrylate sensitivity (e.g. Synechocystis sp. PCC 6803).


Subject(s)
Bacterial Proteins/genetics , Coenzyme A Ligases/genetics , Drug Resistance, Bacterial/genetics , Selection, Genetic , Synechococcus/genetics , Acrylates/pharmacology , Bacterial Proteins/metabolism , Coenzyme A Ligases/metabolism , Drug Resistance, Bacterial/drug effects , Lactic Acid/analogs & derivatives , Lactic Acid/pharmacology , Metabolic Engineering/methods , Microbial Sensitivity Tests , Mutagenesis, Insertional , Mutation , Propionates/pharmacology , Pseudogenes , Synechococcus/drug effects , Synechococcus/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...